Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E MacIntyre

Showing results (261-270 of 294) with videos related to

Pageof 30
Sort By:
Anaesthesia|October 7, 2020
An international multidisciplinary consensus statement on the prevention of opioid-related harm in adult surgical patientsN Levy, J Quinlan, K El-Boghdadly, et al.
Scientific Reports|June 24, 2020
Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALLV Seitz, K Kleo, A Dröge, et al.
Journal of Medicinal Chemistry|November 7, 1998
4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activityG I Stevenson, I Huscroft, A M MacLeod, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeysG J Hom, M J Forrest, T J Bach, et al.
Journal of Medicinal Chemistry|November 7, 1998
Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonistJ J Hale, S G Mills, M MacCoss, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonistsE M Naylor, V J Colandrea, M R Candelore, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailabilityT L Shih, M R Candelore, M A Cascieri, et al.
Transgenic Research|August 22, 2000
Role of the melanocortin-4 receptor in metabolic rate and food intake in miceA S Chen, J M Metzger, M E Trumbauer, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonistD D Feng, T Biftu, M R Candelore, et al.
Journal of Medicinal Chemistry|July 19, 1996
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonistsT Ladduwahetty, R Baker, M A Cascieri, et al.
Pageof 30

Showing results (261-270 of 294) with videos related to

Sort By:
Pageof 30
Anaesthesia|October 7, 2020
An international multidisciplinary consensus statement on the prevention of opioid-related harm in adult surgical patientsN Levy, J Quinlan, K El-Boghdadly, et al.
Scientific Reports|June 24, 2020
Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALLV Seitz, K Kleo, A Dröge, et al.
Journal of Medicinal Chemistry|November 7, 1998
4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activityG I Stevenson, I Huscroft, A M MacLeod, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2001
Beta(3)-adrenoceptor agonist-induced increases in lipolysis, metabolic rate, facial flushing, and reflex tachycardia in anesthetized rhesus monkeysG J Hom, M J Forrest, T J Bach, et al.
Journal of Medicinal Chemistry|November 7, 1998
Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonistJ J Hale, S G Mills, M MacCoss, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
3-Pyridylethanolamines: potent and selective human beta 3 adrenergic receptor agonistsE M Naylor, V J Colandrea, M R Candelore, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
L-770,644: a potent and selective human beta3 adrenergic receptor agonist with improved oral bioavailabilityT L Shih, M R Candelore, M A Cascieri, et al.
Transgenic Research|August 22, 2000
Role of the melanocortin-4 receptor in metabolic rate and food intake in miceA S Chen, J M Metzger, M E Trumbauer, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Discovery of an orally bioavailable alkyl oxadiazole beta3 adrenergic receptor agonistD D Feng, T Biftu, M R Candelore, et al.
Journal of Medicinal Chemistry|July 19, 1996
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonistsT Ladduwahetty, R Baker, M A Cascieri, et al.
Pageof 30